BRIEF published on 05/23/2025 at 15:35, 1 year 3 months ago Vanguard Group Discloses Position in Direct Line Insurance Group Disclosure Takeover Code Vanguard Group Shareholding Direct Line
PRESS RELEASE published on 05/23/2025 at 15:30, 1 year 3 months ago Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc The Vanguard Group, Inc. discloses 5.44% ownership in Direct Line Insurance Group plc as of 22 May 2025 following purchase transactions Vanguard Group Ownership Disclosure Financial Disclosure Direct Line Insurance Group Purchase Transactions
BRIEF published on 05/21/2025 at 15:09, 1 year 3 months ago Vanguard Group Discloses Position in Direct Line Insurance Securities Takeover Code Vanguard Group Stake Direct Line Insurance
BRIEF published on 05/21/2025 at 15:09, 1 year 3 months ago Le groupe Vanguard dévoile sa position dans Direct Line Insurance Titres Groupe Vanguard Code De Prise De Contrôle Miser Assurance Direct Line
PRESS RELEASE published on 05/21/2025 at 15:04, 1 year 3 months ago Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc The Vanguard Group, Inc. discloses a 5.44% stake in Direct Line Insurance Group plc. Purchase of 10 10/11p ordinary shares at 2.95 GBP per unit on 20 May 2025 Vanguard Group Financial Disclosure Share Purchase Stake Disclosure Direct Line Insurance
BRIEF published on 05/20/2025 at 15:12, 1 year 3 months ago Le groupe Vanguard révèle sa position dans Direct Line Insurance Group Actionnariat Groupe Vanguard Code De Prise De Contrôle Divulgation Assurance Direct Line
BRIEF published on 05/20/2025 at 15:12, 1 year 3 months ago The Vanguard Group Discloses Position in Direct Line Insurance Group Disclosure Takeover Code Vanguard Group Shareholding Direct Line Insurance
PRESS RELEASE published on 05/20/2025 at 15:07, 1 year 3 months ago Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc The Vanguard Group, Inc. discloses a 5.44% stake in Direct Line Insurance Group plc as of 19 May 2025. Additional disclosures include dealings with 10 10/11p ordinary shares Securities Vanguard Group Stake Disclosure Dealings Direct Line Insurance Group Plc
BRIEF published on 05/16/2025 at 15:39, 1 year 3 months ago Le groupe Vanguard révèle sa position dans Direct Line Insurance Group Actions Ordinaires Code De Prise De Contrôle Le Groupe Vanguard Divulgation De Position Assurance Direct Line
BRIEF published on 05/16/2025 at 15:39, 1 year 3 months ago The Vanguard Group Discloses Position in Direct Line Insurance Group Ordinary Shares Position Disclosure The Vanguard Group Takeover Code Direct Line Insurance
Published on 09/11/2026 at 04:00, 5 hours 34 minutes ago Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 11 hours 9 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 18 hours 14 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 18 hours 34 minutes ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 09:20, 14 minutes ago Cantourage Expands Portfolio with New Cannabis Active Ingredients for Innovative Compounded Medicines
Published on 09/11/2026 at 09:05, 29 minutes ago ROHM's New High Anti-surge Chip Resistors in "SDR01 Series" Achieve 0.33W Rated Power in 0402 Size
Published on 09/11/2026 at 09:00, 34 minutes ago Homann Holzwerkstoffe publishes its 2026 half-year report
Published on 09/11/2026 at 07:00, 2 hours 34 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 2 hours 34 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 2 hours 34 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 14 hours 4 minutes ago Availability of the 2026 Interim Financial Report
